Clinical Trial Update: CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating CTR-FAPI-guided precision surgery for newly diagnosed medullary thyroid carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medullary Thyroid Carcinoma

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Medullary Thyroid Carcinoma | Phase 3 | Status: RECRUITING